News und Analysen
Eilt: USA erteilen Patent für Blockbuster gegen Hautkrebs. Durchbruch in Krebsforschung. Neuer 332% Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: USA erteilen Patent für Blockbuster gegen Hautkrebs. Neuer 298% Biotech Hot Stock nach 134.452% mit Biogen ($BIIB)
08.02.24 08:03
London (www.aktiencheck.de, Anzeige)
Eilt: USA erteilen Patent für Blockbuster gegen Hautkrebs. Durchbruch in Krebsforschung. Neuer 332% Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: USA erteilen Patent für Blockbuster gegen Hautkrebs. Neuer 298% Biotech Hot Stock nach 134.452% mit Biogen ($BIIB)
08.02.24 08:03
London (www.aktiencheck.de, Anzeige)
Eilt: USA erteilen Patent für Blockbuster gegen Hautkrebs. Durchbruch in Krebsforschung. Neuer 332% Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: USA erteilen Patent für Blockbuster gegen Hautkrebs. Neuer 298% Biotech Hot Stock nach 134.452% mit Biogen ($BIIB)
08.02.24 08:03
London (www.aktiencheck.de, Anzeige)
Neue 1 Billionen $ Aktienchance - 260% Umsatzwachstum - KUV 1. 6 Mio. $ frisches Kapital - Diesen 237% Mental Health Hot Stock jetzt kaufen. 26 mal günstiger als Compass Pathways ($CMPS). Jetzt 233% mit Mentale Gesundheits Aktientip 2024 Numinus Well
Neue 1 Billionen $ Aktienchance - 260% Umsatzwachstum - KUV 1. 6 Mio. $ frisches Kapital - Diesen 237% Hot Stock kaufen
08.02.24 08:18
Vancouver (www.aktiencheck.de , Anzeige)
First Majestic meldet positive Explorationsergebnisse aus den Konzessionsgebieten San Dimas, Santa Elena und Jerritt Canyon
7. Februar 2024, Vancouver, British Columbia, Kanada / IRW-Press / First Majestic Silver Corp. (AG: NYSE; FR: TSX) (das „Unternehmen“ oder „First Majestic“) freut sich, positive
First Majestic Reports Positive Exploration Results at San Dimas, Santa Elena and Jerritt Canyon Properties
February 7, 2024, Vancouver, BC, Canada - First Majestic Silver Corp. (AG: NYSE; FR: TSX) (the "Company" or “First Majestic”) is pleased to announce positive drilling results from its 2023
Mullen Automotive stock gains traction, can it reverse course?
The share price of Mullen Automotive (NASDAQ: MULN) is gaining traction, and it may be on track for a reversal, but the market has given no signal to that effect. At this point, investors holding
Qualcomm extends Apple, Samsung deals, stock up on AI growth
Qualcomm Inc. (NASDAQ: QCOM) bounced off its 50-day moving average and rallied for three sessions in a row after beating earnings estimates for its fiscal first quarter. Among technology stocks,
Qualcomm extends Apple, Samsung deals, stock up on AI growth
Qualcomm Inc. (NASDAQ: QCOM) bounced off its 50-day moving average and rallied for three sessions in a row after beating earnings estimates for its fiscal first quarter. Among technology stocks,
Qualcomm extends Apple, Samsung deals, stock up on AI growth
Qualcomm Inc. (NASDAQ: QCOM) bounced off its 50-day moving average and rallied for three sessions in a row after beating earnings estimates for its fiscal first quarter. Among technology stocks,
GM stock has more upside after another high volume gapper
General Motors Company (NYSE: GM) is suddenly finding another gear.
After slipping below $30.00 in November 2023 (for the first time since the pandemic), shares of the old school automaker have
Chipotle Mexican Grill stock heats up; $3,000 is in the way
Chipotle Mexican Grill (NYSE: CMG) is the best-in-breed among restaurants for many reasons. CEO Brian Niccol resurrected this failing story with a lean into modernization and quality that
Ulta Beauty set for a breakout to new highs
Ulta Beauty Inc. (NASDAQ: ULTA) has grown into the largest beauty retailer in the United States. With nearly 1,400 stores, this consumer discretionary sector leader sells everything from cosmetics
Exxon and Chevron ready to rally: The floor is in for big oil
As sketchy as the outlook for oil prices, a floor has been in place for over a year and is unlikely to be broken. Persistent demand and OPEC help to support the price, while rising production
Exxon and Chevron ready to rally: The floor is in for big oil
As sketchy as the outlook for oil prices, a floor has been in place for over a year and is unlikely to be broken. Persistent demand and OPEC help to support the price, while rising production
Analysts jumped on this stock ahead of earnings; markets love it
Analysts on Wall Street talk to each other about where a stock should or could head shortly, especially when earnings season starts, as their reputations often hang on the power of their
3 Nasdaq stocks likely to make big earnings splashes
The widely followed Nasdaq-100 index is up 13 of the last 14 weeks, a huge move that dates back to Halloween. Booming artificial intelligence plays and hopes of multiple Fed rate cuts this year
Unusual call options in this ETF can lead these stocks to rally
The big players in the market tend to move big, and they also tend to move later in the last innings of the game. In this case, the game is never over, so the innings are measured by where the
3 best tech stocks to buy after earnings (that aren’t META)
Earnings season follows a predictable pattern in which various sectors report relatively closely together. The week of January 29, the big technology stocks reported earnings. The news was mostly
3 best tech stocks to buy after earnings (that aren’t META)
Earnings season follows a predictable pattern in which various sectors report relatively closely together. The week of January 29, the big technology stocks reported earnings. The news was mostly
3 best tech stocks to buy after earnings (that aren’t META)
Earnings season follows a predictable pattern in which various sectors report relatively closely together. The week of January 29, the big technology stocks reported earnings. The news was mostly
Eilt: US-Patent erteilt - Durchbruch in Krebsforschung. Neuer 332% Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). Jetzt 332% mit Biotech Aktientip 2023 Vidac Pharma Hol
Eilt: US-Patent erteilt - Durchbruch in Krebsforschung. Neuer 332% Biotech Hot Stock nach 15.973% mit BioNTech ($BNTX)
07.02.24 08:02
London (www.aktiencheck.de, Anzeige)
Eilt: US-Patent erteilt - Durchbruch in Krebsforschung. Neuer 332% Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). Jetzt 332% mit Biotech Aktientip 2023 Vidac Pharma Hol
Eilt: US-Patent erteilt - Durchbruch in Krebsforschung. Neuer 332% Biotech Hot Stock nach 15.973% mit BioNTech ($BNTX)
07.02.24 08:02
London (www.aktiencheck.de, Anzeige)
Eilt: US-Patent erteilt - Durchbruch in Krebsforschung. Neuer 332% Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). Jetzt 332% mit Biotech Aktientip 2023 Vidac Pharma Hol
Eilt: US-Patent erteilt - Durchbruch in Krebsforschung. Neuer 332% Biotech Hot Stock nach 15.973% mit BioNTech ($BNTX)
07.02.24 08:02
London (www.aktiencheck.de, Anzeige)
Diese Aktie jetzt kaufen: 260% Umsatzwachstum - KUV 1 - 270% Hot Stock erhält 6 Mio. $ frisches Kapital - Riesendeals voraus. 26 mal günstiger als Compass Pathways ($CMPS). Mental Health Hot Stock mit 260% Umsatzwachstum. Jetzt 233% mit Mentale Gesun
Diese Aktie kaufen: 260% Umsatzwachstum - KUV 1. 270% Hot Stock erhält 6 Mio. $ frisches Kapital - Riesendeals voraus
07.02.24 08:18
Vancouver (www.aktiencheck.de, Anzeige)